CFDB - Cystic Fibrosis DataBase

Welcome in CFDB (Cystic Fibrosis DataBase)!

This is a web-based, free access tool for health care professionals, researchers and students to evaluate in real time what are the current evidences about clinical efficacy of interventions in CF.

You'll find more than 1,500 studies divided in 8 sections, including Cochrane reviews, Cochrane protocols, DARE, HTA and Economic reviews, published RCT, published non-RCT, congress abstracts and ongoing trials.

Objective of CFDB (Cystic Fibrosis DataBase)

CFDB is a database and was ideated to classify clinical studies to get answers to specific questions:

  • which interventions are effective, in which groups of CF patients and for which outcomes?
  • to what extent do the results of the literature allow to make decisions for specific clinical issues? What issues need to be studied further?

This tool may help clinicians, researchers, students to have a faster updated view of clinical research in CF by using queries on the main topics in CF care. It could also be helpful to anyone going to design new studies, as it provides a concise description of what is currently known and what issues, on the contrast, need additional research.

Latest articles

Nebulised hypertonic saline for cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2018
  • Wark Peter

Bronchoscopy-guided antimicrobial therapy for cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2018
  • Jain Kamini

Treatment for chronic methicillin‐sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2018
  • Ahmed MI

Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review.

Other Reviews - Other Review

Details
  • 2018
  • Shah GB

VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

primary studies published RCT

Details
  • 2018
  • Keating D

Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.

primary studies published RCT

Details
  • 2018
  • Dezube R

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis - Phase 2|Phase 3 - Not yet recruiting

ongoing trials trial from www.clinicaltrials.gov

Details
  • 2018
  • AlgiPharma AS|Imperial College London|Cystic Fibrosis Foundation Therapeutics|European Cystic Fibrosis Society|University Hospital of Cologne